INCYIncyte
$119.69+29% 1Y
$119.69
$90.3052 weeks$129.88
Valuation
What INCY's price assumes
Incyte trades at 63.7× earnings against 20.8× for the median Biotechnology name.
63.7
Trailing P/E · Biotechnology median 20.8 · 3.06× the Biotechnology median
- Price / sales
- 4.06
Price / sales · today's price, trailing year to Sep 30, 2026
- Price / book
- 4.32
Price / book · today's price, trailing year to Sep 30, 2026
- EV / sales
- 3.54
EV / sales
Details›
- Price / booktoday's price, trailing year to Sep 30, 2026
- 4.32
- EV / EBITtoday's price, trailing year to Sep 30, 2026
- 34.0
- EV / salestoday's price, trailing year to Sep 30, 2026
- 3.54
- Healthcare median P/E497 names
- 27.1
- Biotechnology median P/E238 names
- 20.8
- Market capitalisation203.8 million shares, counted Oct 22, 2026
- $24.4B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Biotechnology
The closest names by size in the same industry